Navigation Links
ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
Date:10/2/2008

Webcast Presentation Scheduled for Monday, October 6, 2008 at 3:00 p.m. EDT

BROOMFIELD, Colo., Oct. 2 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that Richard Brewer, the company's president and chief executive officer, and Dr. Michael Bristow, M.D., ARCA's chairman and chief science and medical officer, will present at the Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008, at 3:00 p.m. EDT in New York City.

ARCA biopharma and Nuvelo, Inc. (Nasdaq: NUVO) announced on September 25, 2008 that they have entered into a definitive merger agreement, expected to create a cardiovascular-focused, late-stage biotechnology company. The presentation will discuss the assets of both companies, including ARCA's lead product Gencaro(TM) (bucindolol hydrochloride) a near-term commercial opportunity, as well as Nuvelo's mid-stage pipeline asset, novel short-acting anticoagulant NU172, to drive long-term growth. ARCA recently announced that the FDA has accepted a New Drug Application for Gencaro. The presentation will also discuss the structure and strategic plan of the combined company, pending the closing of the merger.

A live audio webcast of the presentation will be available online via the ARCA biopharma website at http://www.arcabiopharma.com, the Investor Relations portion of Nuvelo's website at http://www.nuvelo.com or http://www.wsw.com/webcast/jmp7/nuvo/.

About ARCA biopharma

ARCA bio
'/>"/>

SOURCE ARCA biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Helix BioPharma Announces $11.4 Million Private Placement
2. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
3. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
4. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
5. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
6. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
7. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
8. China Biopharma Effects 1 for 100 Reverse Stock Split
9. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
10. Therapure Biopharma Inc. opens for business with first client contracts
11. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 (PRWEB) June 18, 2013 ... time and attendance system in North America, has ... shares employee data and payroll records between ExakTime’s ... Plus automates ExakTime software setup and keeps ... imports employee data from a business’ current payroll ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
(Date:6/18/2013)... 2013  AMRI (NASDAQ: AMRI ) ... , site has received approval to expand ... to handle Schedule 2 and 2N controlled substances. ... Burlington,s physical security and quality ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With ...
(Date:6/18/2013)... Research and Markets ... of the report " DNA Sequencing - ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... human genome variations, development of sequencing technologies, ... sequencers are described as well as companies ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... has been so much media attention focused on the ... finally shedding some light on the issue. Whatever the ... America to cheaper labor. The effects of this are ... It doesnt matter what you are making, whether you ...
... Among the reasons North Carolina Sen. John Edwards polled ... thinks the North American Free Trade Agreement has been a ... voters who are eager to blame the states economic troubles ... really not that short-sighted. Free trade is a part of ...
... Wis.- Gundersen Lutheran Health System is reducing surgery delays ... management of its surgical instruments and trays by using ... Minn.- based Lawson Software. , ,Gundersen Lutheran operates ... of the nation's largest group medical practices, community clinics, ...
Cached Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3A Vote Against Free Trade is a Vote Against Wisconsins Long-Term Interests 2Gunderson Lutheran Implements Instrument Management Systems 2
(Date:6/17/2013)... and algae, is a common component of sugar-free gum ... medical field it,s approved by the FDA as ... during surgery as a substance that opens the blood/brain ... Now Profs. Ehud Gazit and Daniel Segal of Tel ... the Sagol School of Neuroscience, along with their colleague ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further establish ... with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes and ... its third year, this competition continues to grow in ... careers in basic and clinical research," said Nicholas F. ... "We are extremely proud of all that these fellows ...
(Date:6/17/2013)... Amphibian populations are declining worldwide and a major cause ... bullfrogs, but a two-year study shows they can also ... are a tolerant carrier host that just spreads the ... in controlled experimental conditions, they found at least one ... called Bd or a chytrid fungus, can be fatal ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... more foreign children in the classroom, and many of them ... A study by the University of Gerona has assessed the ... that they take at least six years to acquire the ... system that has proven successful in other countries as a ...
... at the University of Leeds have come a step closer ... Their findings, published in the International Journal of ... developed to tackle other cancers should be considered as a ... as tamoxifen, that target a protein responsible for tumour growth, ...
... at The University of Texas Health Science Center at ... study the spread of E. coli , a ... Jennifer Juarez received fellowships from the American Society for ... The ASM fellowship supports professional development and the NIH ...
Cached Biology News:Foreign children take at least 6 years to learn the language used in school 2Foreign children take at least 6 years to learn the language used in school 3Another step toward resisting breast cancer 2UTHealth student earns fellowships to research major source of bacterial infections 2
... Ultrasonic Nebulizers are available in two product models ... these two models is that the 6000AT+ includes ... a drier aerosol for improved detection limits and ... for a range of elements by 10-40 times. ...
...
... For potent inhibition of RNase A-type ribonucleases ... protein of nonhuman origin that binds noncovalently ... RNase A, B, and C). It does ... U1, U2, or CL3. QIAGEN RNase Inhibitor ...
...
Biology Products: